US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
アメリカ
NASDAQ
BUUU Group Ltd (BUUU) 銘柄情報

BUUU Group Ltd (BUUU)

18.88

1.07

(6.01%)

終了 6月16日 5:00AM

18.52

-0.36

(-1.91%)

取引時間後: 8:59AM

BUUU Group Ltd (BUUU) 銘柄情報

個人投資家向けのプロ仕様のツール。

プレミアム

通貨

18.88

( 6.01% )

買値

14.23

売値

25.57

出来高

21,200

18.35 日の範囲 19.32

3.97 52 週間の範囲 26.00

時価総額

前日終値

17.81

始値

18.50

時刻

最終取引時間

財務取引量

US$ 392,751

VWAP

18.526

平均取引量 (3 か月)

US$ 18,495

発行済株式数

16,695,000

配当利回り

PER

-1.05k

1 株当たり利益 (EPS)

-0.02

歳入

6.68M

純利益

-264.27k

BUUU Group Limited, through its subsidiaries, provides design, planning and production of face-to-face event in Hong Kong. The company operates through Event Management and Stage Production segments. The company curates and manages a range of events, including cultural, artistic, recreational, and c... BUUU Group Limited, through its subsidiaries, provides design, planning and production of face-to-face event in Hong Kong. The company operates through Event Management and Stage Production segments. The company curates and manages a range of events, including cultural, artistic, recreational, and corporate promotions. It also offers event management services, such as design and planning, project management, and on-site supervision. In addition, the company provides stage management and technical direction, fabrication, and installation of set elements, as well as sources lighting and visual and audio systems. BUUU Group Limited was founded in 2017 and is headquartered in Cheung Sha Wan, Hong Kong. BUUU Group Limited operates as a subsidiary of BUBI Services Limited. 詳細を表示

セクター

Industrials

業界

Corporate Services

ウェブサイト

bucreation.com

本社

Cheung Sha Wan, Hong Kong

設立

2026

BUUU Group Ltd is listed in the Industrials sector of the ナスダック市場 with ticker BUUU. The last closing price for BUUU was US$17.81. Over the last year, BUUU shares have traded in a share price range of US$ 3.97 to US$ 26.00.

BUUU currently has 16,695,000 shares in issue. The market capitalisation of BUUU is US$315.20 million. BUUU has a price to earnings ratio (PE ratio) of -1,052.79.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 3 - Initial statement of beneficial ownership of securities

Form 3 - Initial statement of beneficial ownership of securities

Form 3 - Initial statement of beneficial ownership of securities

Form 3 - Initial statement of beneficial ownership of securities

Form 3 - Initial statement of beneficial ownership of securities

Form 3 - Initial statement of beneficial ownership of securities

Form SCHEDULE 13D - General Statement of Acquisition of Beneficial Ownership

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	1.45	8.3189902467	17.43	19	15.55	23754	16.55330103	CS
4	-2.12	-10.0952380952	21	26	15.2501	20783	17.44651198	CS
12	3.61	23.6411263916	15.27	26	13.21	17374	18.96713381	CS
26	11.66	161.495844875	7.22	26	6.1	41364	11.6499064	CS
52	14.84	367.326732673	4.04	26	3.97	40656	9.84546469	CS
156	14.84	367.326732673	4.04	26	3.97	40656	9.84546469	CS
260	14.84	367.326732673	4.04	26	3.97	40656	9.84546469	CS

BUUU - Frequently Asked Questions (FAQ)

What is the current BUUU Group Ltd share price?

The current share price of BUUU Group Ltd is US$ 18.88

How many BUUU Group Ltd shares are in issue?

BUUU Group Ltd has 16,695,000 shares in issue

What is the market cap of BUUU Group Ltd?

The market capitalisation of BUUU Group Ltd is USD 315.2M

What is the 1 year trading range for BUUU Group Ltd share price?

BUUU Group Ltd has traded in the range of US$ 3.97 to US$ 26.00 during the past year

What is the PE ratio of BUUU Group Ltd?

The price to earnings ratio of BUUU Group Ltd is -1.05k

What is the cash to sales ratio of BUUU Group Ltd?

The cash to sales ratio of BUUU Group Ltd is 44.5

What is the registered address of BUUU Group Ltd?

The registered address for BUUU Group Ltd is Flat B, 16th Floor, Cheung Sha Wan, Kowloon

What is the BUUU Group Ltd website address?

The website address for BUUU Group Ltd is bucreation.com

Which industry sector does BUUU Group Ltd operate in?

BUUU Group Ltd operates in the Corporate Services sector

price_and_volume

price_and_volume 6分前

Gonna have to bump the A/S then...
He said recently that they are looking at another acquisition...and he will dilute with shares to get it. Agreed - I posted the same, "where's the finance coming from for acquisitions?"...

Supposed 400MM shares going to $GTVH (believe it when

StockItOut

StockItOut 7分前

WKSP Weekly chart: https://schrts.co/IIIuZpgy

CelestialSage6

CelestialSage6 8分前

I understand that Halozyme has not signed any exclusive agreements regarding treatments or indications related to Dupixent, so why is Sanofi collaborating with Alteogen?

Also, Halozyme's mdase patent is being invalidated due to Merck. Alteogen's technology is more advanced than Halozy

Wolf-man jack

Wolf-man jack 10分前

WQLF SAYS: Have Mercy WQLF ahoooooo

Q: Why hasn't CV SCIENCES been accepted in the CMS Medicare Pilot Program?

Ai Generated:

CV Sciences has not been "accepted" into the CMS Medicare Pilot Program because the pilot is a provider-led incentive, not a pro

price_and_volume

price_and_volume 11分前

What reasonable expectation is there of PPS responding?
whether management can successfully execute on the vision they have laid out. Nobody cares about "the company" or "the management" or "their vision" or your two-bit-MBA-tutorials-in-a-post.

Enough of all that garbage.

mrwrn2010

mrwrn2010 14分前

Disagree. The outcome of OxyContin litigation was unknown 9 months to a year ago. You can guess at a variety of outcomes, sure, but it’s not certain. Same thing with human trials - we don’t have positive trial results for anything in the pipeline until we have them. What passes in vitro may not pass

PEACHMAN

PEACHMAN 16分前

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=177680761

IFUS STRONG

price_and_volume

price_and_volume 17分前

I get that, but that's not what I asked.

I'm not bullying you or accusing you of pumping.

You repeatedly point out what you consider to be nefarious shenanigans, so I asked: PPS hasn't effectively changed in THREE YEARS , other than a few short days 1 year ago this wee

Homework.Investwell

Homework.Investwell 23分前

2017 Northwest Biotherapeutics, Inc.
4800 Montgomery Lane, Suite 800

Suite 800 is empty....🤔

Linda lives in Missouri now but headquarters could be moved anywhere...or will they need it?

I think we're going to find out by the end of the sum

Mdk1

Why this paper is highly interesting for Lightwave Logic (GROK)
This is a top-scored paper that strongly validates Lightwave Logic’s Perkinamine™ chromophore series 3 as a leading electro-optic material for next-generation datacenter optics.

Key Reasons Why It Matters:

janice shell

janice shell 32分前

Now that's a real head-scratcher! But shorts have to be smart, so I'd say torso and head.

gitreal

gitreal 35分前

Anyone with half a Brian can see this company is being crazy shorted!

Which half? Torso and head?

HyGro

NWBO could file an FDA application anytime but they haven't and have shown no intent to do so. Instead they are just burning more shareholder cash and if approved, will lose money on every dose because NICE will hammer the reimbursement down below Advent's costs. NWBO will lose money and collaps

US Market News

US Market News 40分前

TotalEnergies SE: Disclosure of Transactions in Own SharesJune 16, 2026 2:00 AM
Business Wire Regulatory News In accordance with the authorizations given by the shareholders’ general meeting on May 29, 2026, to trade on its shares and pursuant to applicable law on share

HyGro

Sorry, not enough. NWBO won't make any profit selling in the UK. NICE hates personalized oncology treatments and won't pay enough for NWBO to make a profit.
That's what counts. And NWBO will go under or just become Advent Contract Manufacturer. They have no cash or credit to fund any sub

biotechinvestor1

biotechinvestor1 44分前

Don’t start spazzing again, Alteogen circus clown. The Sanofi news is old.
Once Merck settles/licenses from Halozyme, Sanofi and all others will follow.
Your Alteogen stole IP from Halozyme and will pay a price for it. You can count on it.
The companies who have signed with Alte

Steady_T

Steady_T 45分前

Your theory will be put to the test after UK approval. I give it 6 months as a guess.

HyGro

What's true is NWBO won't file with the FDA for approval in the U.S. Hasn't done it for years when it could have done it. They know FDA won't accept their P3 trial. How many years are you going to wait to find out???

HyGro

What's True is NWBO won't file with the FDA for approval in the U.S. Hasn't done it for years when it could have done it. They know FDA won't accept their P3 trial. How long are you going to wait to find out???

Mdk1

Google Scholar alert - new article: "A Comparison of Plasmonic Modulator Structures in the O- and C-Band for the 400G/Lane IM/DD Era"
>>> " In ALL cases, the same electro-optic organic material, Lightwave Logic’s PerkinamineTM
chromophore series 3, was used " !
https://ieeexplor

CelestialSage6

CelestialSage6 52分前

Stop talking nonsense. Sanofi is conducting clinical trials using Alteogen's technology; what are your thoughts on this? Did you sense a crisis for Halozyme?

biotechinvestor1

biotechinvestor1 55分前

I love it when Alteogen fanboys post on this board. Nearly every time they show up, Halozyme has a run up.

DR_rugby

DR_rugby 55分前

Prophecy is coming

https://www.cnbc.com/2026/06/16/boj-rate-hike-historic-inflation.html

Japanese rates are going higher

Yen is yet to be stabilize

The great unwinding is coming soon

GLTA

BigBadWolf

BigBadWolf 1時間前

Authorized Shares 1,800,000,000 06/15/2026
Outstanding Shares 1,619,034,363 06/15/2026 >5m
Restricted 480,530,670 06/15/2026 >5m
Unrestricted 1,138,503,693 06/15/2026
Held at DTC 1,011,499,104 06/15/2026 >8m

Authorized Shares 1,800,000,000 06/05/2026

4retire

4retire 1時間前

One has to question why a “cash rich” company would need to raise $20-25 billion by going to bond sales that will be in 7 tranches, ranging from 2 to 30 years. The statement is that it’s for general purposes and to redo some current debt financing.

Based on recent financials, NVDA’

Hsbc Bank Usa Na Capped ...

Great Wall Motor (PK)

Isis Property Trust

BetaPro Bitcoin ETF

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。